SCHEMBL503427

SCHEMBL503427

CC(C)C(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL503322 0.90 LMNA (0.33)
SCHEMBL16576077 0.87 LMNA (0.38)
SCHEMBL19759284 0.87 LMNA (0.38)
SCHEMBL16576087 0.87 LMNA (0.38)
SCHEMBL16576108 0.87 LMNA (0.38)
SCHEMBL16576084 0.87 LMNA (0.38)
SCHEMBL16576097 0.87 LMNA (0.38)
SCHEMBL13541921 0.87 LMNA (0.38)
SCHEMBL16576082 0.87 LMNA (0.38)
SCHEMBL16576094 0.87 LMNA (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5275669-A Degreasing glass, metal, plastic and fiber surfaces ALLIEDSIGNAL INC. (US) 1994-01-04 US claimed
WO-2024133913-A2 SEMIFLUORINATED ALKANE COMPOSITIONS COMPRISING HYOSCYAMINE NOVALIQ GMBH (DE) 2024-06-27 WO disclosed
US-12005033-B2 Compositions comprising mixtures of semifluorinated alkanes NOVALIQ GMBH (DE) 2024-06-11 US disclosed
WO-2024108095-A1 SEMIFLUORINATED ALKANE ANTIBIOTIC COMBINATION COMPOSITIONS FOR TREATMENT OF OCULAR DISORDERS COFFEY MARTIN (US) 2024-05-23 WO disclosed
US-11987623-B2 Stabilized antibody compositions NOVALIQ GMBH (DE) 2024-05-21 US disclosed
EP-4342537-A2 SEMIFLUORINATED ALKANE COMPOSITIONS Novaliq GmbH (DE) 2024-03-27 EP disclosed
EP-3100722-B1 SEMIFLUORINATED ALKANES FOR USE IN SOLUBILIZING MEIBUM NOVALIQ GMBH (DE) 2024-03-20 EP disclosed
US-11896559-B2 Opthalmic compositions comprising F6H8 NOVALIQ GMBH (DE) 2024-02-13 US disclosed
US-11844836-B2 Topical pharmaceutical composition based on semifluorinated alkanes DERMALIQ THERAPEUTICS, INC. (US) 2023-12-19 US disclosed
US-RE49758-E1 Stabilised protein compositions based on semifluorinated alkanes NOVALIQ GMBH (DE) 2023-12-19 US disclosed
EP-1950610-A1 COMPOSITION FOR FORMING UPPER FILM AND METHOD FOR FORMING PHOTORESIST PATTERN JSR Corporation (JP) 2008-07-30 EP disclosed
US-20080124524-A1 Composition For Forming Antireflection Film, Layered Product, And Method Of Forming Resist Pattern JSR CORPORATION (JP) 2008-05-29 US disclosed
US-20080038661-A1 Copolymer and Top Coating Composition JSR CORPORATION (JP) 2008-02-14 US disclosed
EP-1818723-A1 COMPOSITION FOR FORMING ANTIREFLECTION FILM, LAYERED PRODUCT, AND METHOD OF FORMING RESIST PATTERN JSR Corporation (JP) 2007-08-15 EP disclosed
EP-1806370-A1 COPOLYMER AND UPPER FILM-FORMING COMPOSITION JSR Corporation (JP) 2007-07-11 EP disclosed
EP-1708027-A1 UPPER LAYER FILM FORMING COMPOSITION FOR LIQUID IMMERSION AND METHOD OF FORMING PHOTORESIST PATTERN JSR Corporation (JP) 2006-10-04 EP disclosed
EP-1193309-B1 Solvent blend for use in high purity precursor removal AIR PROD & CHEM (US) 2004-11-03 EP disclosed
EP-1193309-A1 Solvent blend for use in high purity precursor removal AIR PRODUCTS AND CHEMICALS, INC. (US) 2002-04-03 EP disclosed
US-5298083-A Exposure of substrate to solvent ALLIEDSIGNAL INC. (US) 1994-03-29 US disclosed
US-5275669-A Degreasing glass, metal, plastic and fiber surfaces ALLIEDSIGNAL INC. (US) 1994-01-04 US disclosed